Achieve Life Sciences (ACHV) Deferred Taxes (2015 - 2017)
Achieve Life Sciences (ACHV) posted Deferred Taxes of -$2.9 million for Q3 2017, down 2260.48% on a QoQ basis from -$124000.0 in Q1 2017, and down 2036.5% year-over-year from $151149.3 in Q3 2016.
Achieve Life Sciences (ACHV) Deferred Taxes (2015 - 2017) Analysis & Trends
Achieve Life Sciences' Deferred Taxes history runs 3 years deep, the most recent figure standing at -$2.9 million for Q3 2017.
- Quarterly Deferred Taxes fell 2036.5% year-over-year to -$2.9 million in Q3 2017, while the trailing twelve-month figure through Dec 2017 was -$3.2 million (down 530.56% YoY) and the FY2017 annual result came in at -$3.1 million, down 505.36% from the prior year.
- Deferred Taxes was -$2.9 million for Q3 2017 at Achieve Life Sciences, down from -$124000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at -$118000.0 in Q1 2016 and bottomed at -$2.9 million in Q3 2017.
- A 3-year average of -$566000.0 and a median of -$127000.0 in 2016 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2016 — Deferred Taxes jumped 68.8% — and 2017, when it plunged 2036.5%.
- Achieve Life Sciences' Deferred Taxes stood at -$407000.0 in 2015, then soared by 68.8% to -$127000.0 in 2016, then sank by 2204.72% to -$2.9 million in 2017.
- Business Quant data shows ACHV's Deferred Taxes at -$2.9 million in Q3 2017, -$124000.0 in Q1 2017, and -$127000.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | -2.93 Mn |
| Mar 31, 2017 | -124,000.00 |
| Dec 31, 2016 | -127,000.00 |
| Sep 30, 2016 | -137,000.00 |
| Jun 30, 2016 | -122,000.00 |
| Mar 31, 2016 | -118,000.00 |
| Dec 31, 2015 | -407,000.00 |